(Q53243272)

12 May 2018

title

High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid beta peptide (Abeta). (English)

1 reference

12 May 2018

author name string

Haugabook SJ

1

1 reference

12 May 2018

Yager DM

2

1 reference

12 May 2018

Eckman EA

3

1 reference

12 May 2018

Golde TE

4

1 reference

12 May 2018

Younkin SG

5

1 reference

12 May 2018

Eckman CB

6

1 reference

12 May 2018

publication date

1 July 2001

1 reference

12 May 2018

Journal of Neuroscience Methods

published in

1 reference

12 May 2018

volume

108

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

171-179

1 reference

12 May 2018

Inflammation and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Neurohormonal Signaling Pathways and the Regulation of Alzheimer beta-Amyloid Precursor Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The toxicity in vitro of beta-amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The C-terminus of the beta protein is critical in amyloidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Calcium ionophore increases amyloid beta peptide production by cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900388-0

7 January 2021

10.1016/S0165-0270(01)00388-0

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018